Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis

监测、流行病学和最终结果 列线图 三阴性乳腺癌 流行病学 医学 乳腺癌 肿瘤科 顶泌 内科学 癌症 癌症登记处 病理
作者
Yinggang Xu,Weiwei Zhang,Jinzhi He,Ye Wang,Rui Chen,Wenjie Shi,Xinyu Wan,Xiaoqing Shi,Xiaofeng Huang,Jue Wang,Xiaoming Zha
出处
期刊:The Breast [Elsevier BV]
卷期号:66: 8-14 被引量:5
标识
DOI:10.1016/j.breast.2022.08.011
摘要

PurposeTriple-negative apocrine carcinoma (TNAC) is a sort of triple-negative breast cancer (TNBC) that is rare and prognosis of these patients is unclear. The present study constructed an effective nomogram to assist in predicting TNAC patients overall survival (OS).MethodsA total of 373 TNAC patients from the surveillance, epidemiology, and end results (SEER) got extracted from 2010 to 2016 and were divided into training (n = 261) and external validation (n = 112) groups (split ratio, 7:3) randomly. A Cox regression model was utilized to creating a nomogram according to the risk factors affecting prognosis. The predictive capability of the nomogram was estimated with receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA).ResultsMultivariate Cox regression analysis revealed age, surgery, chemotherapy, stage, and first malignant primary as independent predictors of OS. A prediction model was constructed and virtualized using the nomogram. The time-dependent area under the curve (AUC) showed satisfactory discrimination of the nomogram. Good consistency was shown on the calibration curves in OS between actual observations and the nomogram prediction. What's more, DCA showed that the nomogram had incredible clinical utility. Through separating the patients into groups of low and high risk group that connects with the risk system that shows a huge difference between the low-risk and high risk OS (P < 0.001).ConclusionTo predict the OS in TNAC patients, the nomogram utilizing the risk stratification system that is corresponding. These tools may help to evaluate patient prognosis and guide treatment decisions.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
含糊的无声完成签到 ,获得积分10
1秒前
魔幻的莫茗完成签到 ,获得积分10
1秒前
Melody发布了新的文献求助10
1秒前
tyj完成签到,获得积分10
1秒前
爱撒娇的砖头完成签到,获得积分10
3秒前
数乱了梨花完成签到 ,获得积分0
4秒前
Joy完成签到,获得积分10
10秒前
仙女完成签到 ,获得积分10
12秒前
正一笑完成签到,获得积分10
14秒前
魁梧的沛萍完成签到 ,获得积分10
15秒前
17秒前
小瑄完成签到 ,获得积分10
19秒前
zz发布了新的文献求助10
22秒前
文献狗完成签到,获得积分10
24秒前
25秒前
清爽念柏完成签到 ,获得积分10
25秒前
26秒前
舒仲完成签到,获得积分10
27秒前
30秒前
王柯完成签到 ,获得积分10
31秒前
yindi1991完成签到 ,获得积分10
31秒前
32秒前
Robby完成签到 ,获得积分10
32秒前
32秒前
li完成签到,获得积分10
34秒前
董家旭发布了新的文献求助10
36秒前
贪玩的秋柔举报liujinjin求助涉嫌违规
38秒前
aixiaoming0503完成签到,获得积分10
38秒前
顺顺顺完成签到,获得积分10
40秒前
43秒前
罗格朗因完成签到 ,获得积分10
45秒前
SciGPT应助董家旭采纳,获得10
46秒前
光之战士完成签到 ,获得积分10
47秒前
小昊完成签到,获得积分10
48秒前
48秒前
852应助温暖元容采纳,获得10
51秒前
懒得起名字完成签到 ,获得积分10
51秒前
彦凝毓完成签到,获得积分10
54秒前
这么年轻压根睡不着完成签到 ,获得积分10
54秒前
大个应助科研通管家采纳,获得10
55秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 生物化学 化学工程 物理 计算机科学 复合材料 内科学 催化作用 物理化学 光电子学 电极 冶金 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6021843
求助须知:如何正确求助?哪些是违规求助? 7636970
关于积分的说明 16167100
捐赠科研通 5169682
什么是DOI,文献DOI怎么找? 2766529
邀请新用户注册赠送积分活动 1749627
关于科研通互助平台的介绍 1636662